Serum immunosuppressive acidic protein doubling time as a prognostic factor for recurrent renal cell carcinoma after nephrectomy

Urology

Volumn 68, Issue 6, 2006, Pages 1178-1182

  Araki, Kazuhiro ^a   Igarashi, Tatsuo ^a,b   Tobe, Toyofusa ^a   Mizoguchi, Kenichi ^a   Suzuki, Hiroyoshi ^a   Furuya, Yuzo ^a   Ichikawa, Tomohiko ^a   Nakatsu, Hiro Omi ^c   Ito, Haruo ^a  

^a CHIBA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b CHIBA UNIVERSITY   (Japan)

^c ASAHI GENERAL HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOSUPPRESSIVE ACID PROTEIN;

ADULT; AGED; ARTICLE; CANCER GRADING; CANCER LOCALIZATION; CANCER PATIENT; CANCER SIZE; CANCER STAGING; CANCER SURGERY; COMPARATIVE STUDY; FEMALE; HUMAN; KIDNEY CARCINOMA; MAJOR CLINICAL STUDY; MALE; MEDICAL ASSESSMENT; MULTIVARIATE ANALYSIS; NEPHRECTOMY; PATIENT INFORMATION; PATIENT MONITORING; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION; RECURRENT CANCER; SEX RATIO; SURVIVAL RATE; SURVIVAL TIME; UNIVARIATE ANALYSIS;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, RENAL CELL; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; JAPAN; KIDNEY NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM PROTEINS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; NEPHRECTOMY; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL RATE; TUMOR MARKERS, BIOLOGICAL;

EID: 33845335201     PISSN: 00904295     EISSN: 15279995     Source Type: Journal    
DOI: 10.1016/j.urology.2006.08.1071     Document Type: Article

References (21)

1. McNichols D.W., Segura J.W., and DeWeerd J.H. Renal cell carcinoma: long-term survival and late recurrence. J Urol 126 (1981) 17-23
2. Elson P.J., Witte R.S., and Trump D.L. Prognostic factors for survival in patients with recurrent or metastatic renal cell carcinoma. Cancer Res 48 (1988) 7310-7313
3. Igarashi T., Tobe T., Kuramochi H., et al. Serum immunosuppressive acidic protein as a potent prognostic factor for patients with metastatic renal cell carcinoma. Jpn J Clin Oncol 31 (2001) 13-17
4. Ueda T. Serum immunosuppressive acidic protein in renal cell carcinoma. Urol Res 14 (1986) 101-103
5. Igarashi T., Murakami S., Tanaka M., et al. Preoperative grading of renal cell carcinoma by plasma immunosuppressive acidic protein level and tumor diameter using discriminant analysis. Jpn J Urol 84 (1993) 884-889
6. Igarashi T., Murakami S., Isaka S., et al. Serum immunosuppressive acidic protein as a tumor marker for renal cell carcinoma. Eur Urol 19 (1991) 332-335
7. Pummer K., Purstner P., Auner H.L., et al. Serum immunosuppressive acid protein predicts lymph node metastases in patients with renal cell carcinoma. Br J Urol 73 (1994) 612-614
8. Mani S., Todd M.B., Katz K., et al. Prognostic factors for survival in patients with metastatic renal cancer treated with biological response modifiers. J Urol 154 (1995) 35-40
9. Citterio G., Bertuzzi A., Tresoldi M., et al. Prognostic factors for survival in metastatic renal cell carcinoma: retrospective analysis from 109 consecutive patients. Eur Urol 31 (1997) 286-291
10. Lissoni P., Barni S., Ardizzoia A., et al. Prognostic factors of the clinical response to subcutaneous immunotherapy with interleukin-2 alone in patients with metastatic renal cell carcinoma. Oncology 51 (1994) 59-62
11. Papadopoulos I., Rudolph P., Weichert-Jacobsen K., et al. Prognostic indicators for response to therapy and survival in patients with metastatic renal cell cancer treated with interferon alpha-2 beta and vinblastine. Urology 48 (1996) 373-378
12. Aaltomaa S., Lipponen P., Ala-Opas M., et al. Prognostic value of Ki-67 expression in renal cell carcinomas. Eur Urol 31 (1997) 350-355
13. Pich A., Chiusa L., and Margaria E. Prognostic relevance of AgNORs in tumor pathology. Micron 31 (2000) 133-141
14. Shibata Y., Tamura K., and Ishida N. Cultured human monocytes, granulocytes and a monoblastoid cell line (THP-1) synthesize and secrete immunosuppressive acidic protein (a type of alpha 1-acid glycoprotein). Microbiol Immunol 28 (1984) 99-111
15. Shibata Y., Tamura K., and Ishida N. In vivo analysis of the suppressive effects of immunosuppressive acidic protein, a type of alpha 1-acid glycoprotein, in connection with its high level in tumor-bearing mice. Cancer Res 43 (1983) 2889-2896
16. Igarashi T., Murakami S., Takahashi H., et al. Mechanism of elevation of plasma immunosuppressive acidic protein level in renal cell carcinoma. JPN J Tumor Marker Res 10 (1995) 25-27
17. Kurzrock R., Estrov Z., Ku S., et al. Interleukin-1 increases expression of the LYT-10 (NFkappaB2) proto-oncogene/transcription factor in renal cell carcinoma lines. J Lab Clin Med 131 (1998) 261-268
18. Miki S., Iwano M., Miki Y., et al. Interleukin-6 (IL-6) functions as an in vitro autocrine growth factor in renal cell carcinomas. FEBS Lett 250 (1989) 607-610
19. Casamassima A., Picciariello M., Quaranta M., et al. C-reactive protein: a biomarker of survival in patients with metastatic renal cell carcinoma treated with subcutaneous interleukin-2 based immunotherapy. J Urol 173 (2005) 52-55
20. Atzpodien J., Royston P., Wandert T., et al. Metastatic renal carcinoma comprehensive prognostic system. Br J Cancer 88 (2003) 348-353
21. Miyata Y., Koga S., Nishikido M., et al. Predictive values of acute phase reactants, basic fetoprotein, and immunosuppressive acidic protein for staging and survival in renal cell carcinoma. Urology 58 (2001) 161-164